Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Plasma-Cell Myeloma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT00075608
What this trial is testing

2nd Autologous Stem Cell Transplant in Patients With Persistent/Recurrent (AL) Amyloidosis

Who this might be right for
Multiple MyelomaPlasma Cell Neoplasm
Boston Medical Center 12
Early research (Phase 1)Active Not RecruitingNCT06042725
What this trial is testing

MC210808 Venetoclax in Combination With Lenalidomide and Dexamethasone (Ven-Rd), Daratumumab and Dexamethasone (Ven-Dd), or Daratumumab-Lenalidomide-Dexamethasone (Ven-DRd) for the Treatment of Multiple Myeloma

Who this might be right for
Multiple Myeloma
Mayo Clinic 16
Testing effectiveness (Phase 2)Active Not RecruitingNCT04439110
What this trial is testing

Testing Ado-Trastuzumab Emtansine as a Potential Targeted Treatment in Cancers With HER2 Genetic Changes (MATCH-Subprotocol Q)

Who this might be right for
Advanced LymphomaAdvanced Malignant Solid NeoplasmHematopoietic and Lymphoid Cell Neoplasm+3 more
National Cancer Institute (NCI) 38
Early research (Phase 1)UnknownNCT04003168
What this trial is testing

Human BCMA Targeted T Cells Injection Therapy for BCMA-positive Relapsed/Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Hrain Biotechnology Co., Ltd. 18
Early research (Phase 1)Study completedNCT00398515
What this trial is testing

Lenalidomide and Temsirolimus in Treating Patients With Previously Treated Multiple Myeloma

Who this might be right for
Refractory Multiple MyelomaStage II Multiple MyelomaStage III Multiple Myeloma
National Cancer Institute (NCI) 25
Testing effectiveness (Phase 2)Ended earlyNCT03758417
What this trial is testing

LCAR-B38M CAR-T Cells, a Chimeric Antigen Receptor T-cell (CAR-T) Therapy Directed Against B-cell Maturation Antigen (BCMA) in Chinese Participants With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Nanjing Legend Biotech Co. 123
Testing effectiveness (Phase 2)Active Not RecruitingNCT07150091
What this trial is testing

Sub-study of Belantamab Mafodotin (GSK2857916) in Combination With Nirogacestat, Lenalidomide, and Dexamethasone in Participants With RRMM

Who this might be right for
Multiple Myeloma
GlaxoSmithKline 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT06566547
What this trial is testing

GR1803 Injection in Patients With Relapsed/Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Genrix (Shanghai) Biopharmaceutical Co., Ltd. 116
Not applicableStudy completedNCT05961215
What this trial is testing

Scalp Cooling to Prevent Hair Loss in Patients Undergoing Stem Cell Transplantation for Multiple Myeloma

Who this might be right for
Multiple Myeloma
Cedars-Sinai Medical Center 31
Early research (Phase 1)Study completedNCT03242889
What this trial is testing

Subcutaneous Delivery of JNJ-54767414 (Daratumumab) in Japanese Participants With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Janssen Pharmaceutical K.K. 6
Testing effectiveness (Phase 2)Study completedNCT02654990
What this trial is testing

Panobinostat/Bortezomib/Dexamethasone in Relapsed or Relapsed-and-refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
pharmaand GmbH 248
Not applicableStudy completedNCT00964821
What this trial is testing

Flu Vaccine in Preventing Influenza Infection in Healthy Volunteers and in Patients Who Have Undergone Stem Cell Transplant

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+4 more
City of Hope Medical Center 459
Not applicableStudy completedNCT00060021
What this trial is testing

Acupuncture in Treating Mucositis-Related Pain Caused by Chemotherapy in Patients Undergoing Stem Cell Transplantation

Who this might be right for
Cancer
National Cancer Institute (NCI)
Large-scale testing (Phase 3)Study completedNCT00869206
What this trial is testing

Zoledronic Acid in Treating Patients With Metastatic Breast Cancer, Metastatic Prostate Cancer, or Multiple Myeloma With Bone Involvement

Who this might be right for
Breast AdenocarcinomaDS Stage I Plasma Cell MyelomaDS Stage II Plasma Cell Myeloma+4 more
Alliance for Clinical Trials in Oncology 1,822
Not applicableAvailableNCT04771078
What this trial is testing

Expanded Access Protocol (EAP) for Participants Receiving Idecabtagene Vicleucel That is Nonconforming for Commercial Release

Who this might be right for
Multiple Myeloma
Celgene
Large-scale testing (Phase 3)Looking for participantsNCT06952478
What this trial is testing

Compare Pharmacokinetics, Efficacy and Safety of Subcutaneous CT-P44 and Darzalex Faspro in Combination With Lenalidomide and Dexamethasone in Patients With Refractory or Relapsed Multiple Myeloma

Who this might be right for
Refractory or Relapsed Multiple Myeloma
Celltrion 486
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05054478
What this trial is testing

Primary Plasma Cell Leukemia: a Prospective Phase 2 Study Incorporating Daratumumab to Chemotherapy and Stem Cell Transplantation

Who this might be right for
Plasma Cell Leukemia
Assistance Publique - Hôpitaux de Paris 29
Testing effectiveness (Phase 2)Ended earlyNCT00675428
What this trial is testing

Study of Natalizumab in Relapsed/Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Biogen 6
Early research (Phase 1)Active Not RecruitingNCT05556798
What this trial is testing

Belantamab Mafodotin in Combination With Nirogacestat and Pomalidomide in People With Multiple Myeloma That Has Not Responded to Treatment or Has Come Back After Treatment

Who this might be right for
Multiple Myeloma
Memorial Sloan Kettering Cancer Center 9
Early research (Phase 1)Ended earlyNCT03379584
What this trial is testing

A Safety Study of SGN-CD48A in Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma
Seagen Inc. 14
Next Page